Skip to content

LimFlow ARC AC-US-23Recalls & reported problems

Inari Medical, Inc. · The LimFlow ARC is intended to facilitate placement and positioning of guidewires and catheters within the peripheral vasculature. The LimFlow ARC is not intended for use in the coronary or cerebral vasculature · Class 2

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00850041730158), received between Jul 12, 2024 and Mar 14, 2025 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Fracture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fracture2
  • Break1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Vascular Dissection1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 14, 2025Fracture; Fracture

    THE PATIENT HAD A HEAVILY CALCIFIED AND TORTUOUS ANATOMY, WITH THE INTENDED ARTERIOVENOUS FISTULA (AVF) PLANNED FROM THE ANTERIOR TIBIAL ARTERY (ATA) TO THE ANTERIOR TIBIAL VEIN (ATV). THIS WAS DR. (B)(6) FIRST CASE AT (B)(6) AND THE FACILITY'S SECOND CASE OVERALL. ASSISTING VASCULAR SURGEON DR. (B)(6) AND FELLOW (B)(6) WERE BOTH SCRUBBED IN, HAVING PARTICIPATED IN THE FIRST CASE AT (B)(6). GIVEN THE PATIENT'S SEVERE CALCIFICATION AND TORTUOUS ANATOMY, ALONG WITH THE LIMITED DATA AVAILABLE ON AVF CREATION FROM THE ATA TO THE ATV, DR. (B)(6) WAS BRIEFED ON THE CHALLENGES EXPECTED IN THIS CASE. HOWEVER, THE PRIMARY DRIVER FOR PROCEEDING WAS THE PATIENT'S REFUSAL OF AMPUTATION, ESPECIALLY CONSIDERING THEIR CONTRALATERAL ABOVE THE KNEE AMPUTATION (AKA). THE PATIENT WAS FITTED WITH A 7FR 45CM SHEATH, THOUGH IT COULD NOT BE FULLY ADVANCED DOWN THE SUPERFICIAL FEMORAL ARTERY (SFA) DUE TO CALCIFICATION. ADDITIONALLY, A LARGE PANNUS LED TO A LOWER FEMORAL STICK. TO PREPARE THE ATA, ATHERECTOMY (CSI) AND BALLOON ANGIOPLASTY (4.0 POBA) WERE PERFORMED. MULTIPLE ATTEMPTS WERE MADE TO CREATE THE AVF USING THE ARC AND V-CEIVER DEVICES. AT ONE POINT, WHEN (B)(6) (FELLOW) ATTEMPTED TO DEPLOY THE NE

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21612627 ↗
  • MalfunctionJan 22, 2025Fracture; Fracture

    A PATIENT WITH CLTI (CHRONIC LIMB-THREATENING ISCHEMIA), CLASSIFIED AS RUTHERFORD CATEGORY 5, UNDERWENT A TADV PROCEDURE (TRANSCATHETER ARTERIALIZATION OF DEEP VEINS) USING THE LIMFLOW DEVICES ON (B)(6) 2025. THE ARC DEVICE WAS FLUSHED WITH VIPERSLIDE AT THE PHYSICIAN'S DISCRETION AND INSERTED INTO THE BODY FOR USE. THE COMMAND GUIDWIRE WAS USED TO DELIVER THE DEVICE. THE PHYSICIAN ORIGINALLY HAD DIFFICULTY THROWING THE NEEDLE FORWARD. THE ACCOUNT MANAGER REMINDED THE PHYSICIAN THAT THE VESSEL WAS EXTREMELY CALCIFIED. AFTER MULTIPLE ATTEMPTS TO SNARE INTO THE V-CEIVER, THE PHYSICIAN NOTICED THE NEEDLE WAS NO LONGER COMMUNICATING TO THE SLIDER. AT THIS MOMENT IT WAS DECIDED TO WALK OUT THE ARC DEVICE. ONCE THE DEVICE WAS OUT OF THE BODY, IT NOTICED THAT THE WIRE WAS WRAPPED MULTIPLE TIMES AROUND THE CATHETER AND THAT THE MONORAIL TIP OF THE CATHETER BROKE OFF. THERE WERE NO REMNANTS OF THE DEVICE LEFT IN THE BODY. THE PHYSICIAN PULLED OUT ANOTHER ARC DEVICE AND CROSSED THE ANATOMY SUCCESSFULLY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21213567 ↗
  • MalfunctionJul 12, 2024Break; Break

    THE PATIENT PRESENTED FOR TREATMENT WITH THE LIMFLOW SYSTEM. THE ANATOMY OF THE TIBIAL ARTERIES WERE EXTREMELY CALCIFIED. PRIOR TO THE LIMFLOW PROCEDURE, THE PHYSICIAN ATTEMPTED AN OFF LABEL DEEP VEIN ARTERIALIZATION AND FAILED TO PENETRATE THE ARTERIAL CALCIFIED WALL. ANGIOPLASTY WAS PERFORMED WITH 4X80MM BALLOON ACROSS THE DISTAL POPLITEAL AND ATA. THE CALCIUM WAS SIGNIFFICANT. AFTER THE LIMFLOW ARC & V-CEIVER WERE POSITIONED FOR CROSSING, SEVERAL ATTEMPTS WERE MADE TO SUCCESSFULLY CROSS ATA TO ANTERIOR TIBIAL VEIN (ATV). A NUMBER OF DEPLOYMENTS WERE ATTEMPTED (N=15). ON SEVERAL OF THESE ATTEMPTS (N~7), THE NEEDLE OF THE ARC WAS UNABLE TO PENETRATE THE CALCIFIED ARTERIAL WALL. NUMEROUS ROTATIONS OF THE CATHETER BY THE OPERATOR, AT THE DIRECTION OF THE LIMFLOW REPRESENTATIVE, WERE DONE TO MAKE THE CROSSING, YET WERE ULTIMATELY UNSUCCESSFUL. AT THE MOMENT OF THE DEVICE FAILURE, THE PHYSICIAN WAS TRYING TO REPOSITION THE DEVICE BY PULLING PROXIMALLY TO ATTEMPT CROSSING AT A NEW VESSEL POSITION. THE LIMFLOW ARC CATHETER TIP SEPARATED FROM THE MAIN CATHETER. THE NEEDLE WAS EXPOSED AND RECOVERED WITHOUT INCIDENT. THE TIP WAS ATTEMPTED TO BE REMOVED WITH ENDOVASCULAR METHODS, HOWEVER FA

    Patient problems: Vascular Dissection

    MAUDE report 19732188 ↗

Other Catheter For Crossing Total Occlusions devices

All Catheter For Crossing Total Occlusions devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.